Bain Capital Public Equity Management Ii, LLC Ironwood Pharmaceuticals Inc Transaction History

Bain Capital Public Equity Management Ii, LLC

  • $2.08 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$8.58 - $14.01 $4.94 Million - $8.06 Million
-575,301 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$8.22 - $14.0 $187,851 - $319,942
-22,853 Reduced 3.82%
575,301 $7.66 Million
Q3 2019

Nov 14, 2019
SELL
$8.59 - $10.96 $1.79 Million - $2.29 Million
-208,550 Reduced 25.85%
598,154 $5.14 Million
Q2 2019

Aug 14, 2019
BUY
$9.8 - $12.89 $7.91 Million - $10.4 Million
806,704 New
806,704 $8.83 Million

Others Institutions Holding IRWD

# of Institutions
246
Shares Held
170M
Call Options Held
11.2M
Put Options Held
28.5K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $642M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Bain Capital Public Equity Management Ii, LLC Portfolio

Follow Bain Capital Public Equity Management Ii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Public Equity Management Ii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Public Equity Management Ii, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email